Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Envoy Medical Inc COCH
$0.71
▲ +2.44%
(+$0.02)
Open
$0.70
Prev Close
$0.69
Day Range
$0.68 – $0.72
52W Range
$0.36 – $1.89
Market Cap
$54.87M
Beta
2.04
EPS (TTM)
$-0.65
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-03-02 |
| Shares Out. | 76,880,000 |
| Website | envoymedical.com/ ↗ |
| Phone | 16513618000 |
| Employees | 47 |
| Revenue | $51,000 |
| Gross Profit | -$227,000 |
| Net Income | -$6.0M |
| Free Cash Flow | -$21.7M |
| Total Assets | $23.9M |
| Total Liabilities | $20.3M |
| Equity | $3.3M |
About Envoy Medical Inc
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Envoy Medical Inc is a publicly traded company under the ticker symbol COCH on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-09-01)